FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

331829005: Betamethasone+salicylic acid 0.05/3% scalp application (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    468564013 Betamethasone+salicylic acid 0.05/3% scalp application en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1192589010 Betamethasone+salicylic acid 0.05/3% scalp application (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Betamethasone+salicylic acid 0.05/3% scalp application Is a Product containing betamethasone and salicylic acid (medicinal product) false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent kératolytique false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salicylic acid (substance) false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent topique false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application Has manufactured dose form forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Some
    Betamethasone+salicylic acid 0.05/3% scalp application Is a Product containing salicylic acid in topical dosage form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start